Product
Donor-derived Mesenchymal Stromal Cells
1 clinical trial
3 indications
Indication
Kidney TransplantIndication
kidney transplantIndication
Renal Transplant RecipientClinical trial
Donor-derived Mesenchymal Stromal Cells, Alemtuzumab, Co-stimulation Blockade and Sirolimus for Tolerance Induction in Adult Kidney Allograft Recipients (ITN062ST)Status: Active (not recruiting), Estimated PCD: 2027-12-01